Press Releases

Enesi Pharma, an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the University of Adelaide to develop a new thermostable, solid dose DNA vaccine for Zika virus to prevent infection...

AbbVie and I-Mab announced that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an innovative anti-CD47 monoclonal antibody internally discovered and developed by I-Mab for the...

X 3 Tablet Press incorporates production capabilities and versatility traditionally limited to large-scale production machines State-of-the-art-tableting technology meets the midrange segment at last. The days of having to compromise are over. KORSCH is introducing a groundbreaking mid-range tablet press incorporating...

Sanofi and GSK today started the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi and GSK, uses the same recombinant protein-based technology as one of Sanofi’s seasonal influenza vaccines with...

Clinerion's Patient Network Explorer will leverage Maxer's extended network of relations in the international healthcare sector to access promising business opportunities and expand Clinerion’s patient coverage into Italy, promoting and delivering clinical trials-related solutions. Clinerion and Maxer will cooperate to...

FedEx Logistics, a subsidiary of FedEx Corp., announced the opening of another Foreign Trade Zone (FTZ) location in El Paso, Texas, U.S. The site in El Paso is the latest FTZ facility to be opened by FedEx Logistics in...

Roche announced that it will launch a SARS-CoV-2 Rapid Antigen Test, in late September, for markets accepting the CE Mark. Roche also intends to file for Emergency Use Authorisation (EUA) to the U.S. FDA. The SARS-CoV-2 Rapid Antigen Test is...